Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Outcomes With Periarticular Liposomal Bupivacaine Injection vs Adductor Canal Block After Primary Total Knee Arthroplasty

NCT02863120 is registered in ClinicalTrials.gov with Texas Orthopaedics, Sports and Rehabilitation Associates as lead sponsor.

NCT NCT02863120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02863120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Outcomes With Periarticular Liposomal Bupivacaine Injection vs Adductor Canal Block After Primary Total Knee Arthroplasty
Lead sponsor
Texas Orthopaedics, Sports and Rehabilitation Associates
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2016
Completion date
December 31, 2019
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis